Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients

Keywords

Medicine, Beta blocker, Internal medicine, Chemotherapy, Ovarian cancer

References

• Beta-blockers May Reduce Intrusive Thoughts in Newly Diagnosed Cancer PatientsMonica Lindgren, Christopher P. Fagundes, Catherine M. Alfano — 2012
• Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.Florian Heitz, Andreas du Bois, Philipp Harter — 2013
• Beta blocker use and ovarian cancer survival: A retrospective cohort studyRamez Eskander, Leona Bessonova, Connie G. Chiu — 2012
• Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort studySigrun Alba Johannesdottir, Morten Schmidt, Gary Phillips — 2013
• Survival Analysis: A Self-Learning TextMark Carpenter, David G. Kleinbaum — 1997
• Stress Hormone–Mediated Invasion of Ovarian Cancer CellsAnil K. Sood, Robert Bhatty, Aparna A. Kamat — 2006
• β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.Jing Tang, Zhijie Li, Lan Lu — 2013
• Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.Anil K. Sood, Guillermo N. Armaiz-Peña, Jyotsnabaran Halder — 2010
• Impact of beta blockers on epithelial ovarian cancer survival.E. Diaz, Beth Y. Karlan, Andrew J. Li — 2011
• Surgical Stress Promotes Tumor Growth in Ovarian CarcinomaJeong‐Won Lee, Mian M.K. Shahzad, Yvonne G. Lin — 2009
• Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaPremal H. Thaker, Liz Y. Han, Aparna A. Kamat — 2006
• Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.Susan K. Lutgendorf, Steve W. Cole, Erin S. Costanzo — 2003
• Nonparametric Estimation from Incomplete ObservationsEdward L. Kaplan, Paul Meier — 1958
• Cancer esearch oenvironment and Immunology Sympathetic Nervous System Induces a Metastatic R tch in Primary Breast CancerÉrica, Veera, W. Lily — 2010
• Healthcare informatics.Marion J. Ball, J. Douglas — 1990
• Beta blockers: A new role in chemotherapyA. Nagaraja, Nouara C. Sadaoui, S. Lutgendorf — 2013
• Regression Models and Life-TablesD., R., Cox

Cited by

• Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?Kristen Bunch, Christina M. Annunziata — 2015
• Reply to beta blockers in epithelial ovarian cancer and beta‐blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person‐time bias?Premal H. Thaker, Diana L. Urbauer, Anil K. Sood — 2016
• Beta‐blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person‐time bias?Sigrún Alba Jóhannesdóttir Schmidt, Morten Schmidt — 2016
• Sympathetic nervous system regulation of the tumour microenvironmentSteve W. Cole, Archana S. Nagaraja, Susan K. Lutgendorf — 2015
• Beta‐blockers in epithelial ovarian cancerAjit Venniyoor — 2016
• Re-Use of Established Drugs for Anti-Metastatic IndicationsFrank Entschladen, D Thyssen, David Drell — 2016
• The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer.Hannah Woopen, Rolf Richter, Fakher Ismaéel — 2016
• Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancerTianyi Huang, Elizabeth M. Poole, A. Heather Eliassen — 2016
• Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.Lars Ivo Partecke, Sven Speerforck, André Käding — 2016
• Role of sympathetic nerves in the establishment of metastatic breast cancer cells in boneFlorent Elefteriou — 2016
• Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis.Janick Weberpals, Lina Jansen, Prudence R. Carr — 2016
• Ovarialkarzinom: Betablockertherapie im FokusPeter Leiner — 2016
• Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibitionLiat Sorski, Rivka Melamed, Pini Matzner — 2016
• YAP/TAZ as therapeutic targets in cancerFrancesca Zanconato, Giusy Battilana, Michelangelo Cordenonsi — 2016
• Bevacizumab induced hypertension in gynecologic cancer: Does it resolve after completion of therapy?Bradley R. Corr, Christopher Breed, Jeanelle Sheeder — 2016
• NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamilJinhyuk Fred Chung, Calvin J. Yoon, Seon Ah Cheon — 2016
• Association of ovarian tumor β2-adrenergic receptor status with ovarian cancer risk factors and survivalTianyi Huang, Shelley S. Tworoger, Jonathan L. Hecht — 2016
• The Combined Blockade of &bgr;-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer OutcomesItay Ricon‐Becker, Jonathan G. Hiller, Shamgar Ben‐Eliyahu — 2016
• Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.William P. Parker, Christine M. Lohse, Harras B. Zaid — 2017
• The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma.Ahmed Al‐Niaimi, Elizabeth L. Dickson, Cassandra Albertin — 2016

Related papers

• Measuring the incidence of acute myocardial infarction: the problem of possible acute myocardial infarction.Craig A. Martin, M. Hobbs, Bruce K. Armstrong — 2009
• 5-year mortality rate in patients with suspected acute myocardial infarction in relation to early diagnosis.Johan Herlitz, Aring . Hjalmarson, B.W. Karlson — 1988
• Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnosesByung‐Joon Park, Mee‐Kyung Cha, Il-Han Kim — 2014
• The second myocardial infarction: Is there any difference in symptoms and prehospital delay compared to the first myocardial infarction?Ulrica Strömbäck, Åsa Engström, Robert Lundqvist — 2018
• circKIF4A sponges miR-127 to promote ovarian cancer progressionShunliang Sheng, Yi Hu, Furong Yu — 2020
• Ovarian cancer.George Coukos, Andrew Berchuck, Robert F. Ozols — 2002